Prime Minister Narendra Modi announced plans to establish the first Jan Aushadhi Kendra in Guyana, extending India’s initiative of providing high-quality, affordable generic medicines to the South American nation. The move marks a milestone in India’s global healthcare outreach and strengthens bilateral ties with Guyana.
The announcement came during PM Modi’s visit to Georgetown, where he held talks with Guyana’s President, Dr. Mohamed Irfaan Ali. This visit, the first by an Indian Prime Minister to Guyana in 56 years, is part of a broader diplomatic tour including Nigeria and Brazil.
Strengthening India-Guyana Healthcare Collaboration
“India is a key supplier of pharmaceutical products to Guyana. We are committed to enhancing this collaboration by increasing pharma exports and setting up a Jan Aushadhi Kendra in Guyana,” PM Modi stated at a joint press conference. The initiative, operational in the coming months, will offer affordable medicines to Guyana’s population, addressing healthcare accessibility challenges.
Jan Aushadhi Kendras: Transforming Lives
Jan Aushadhi Kendras (JAKs), part of the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), aim to provide quality generic medicines at low prices, particularly benefiting economically disadvantaged groups. With over 12,600 centers across India, JAKs have revolutionized healthcare affordability, with leading states like Uttar Pradesh (2,210 centers) and Kerala (1,228 centers) spearheading the initiative.
Diplomacy and Healthcare Equity
The establishment of a Jan Aushadhi Kendra in Guyana aligns with India’s goal of ensuring global healthcare equity. The move highlights India’s role as a global pharmaceutical leader while fostering partnerships to address international healthcare challenges.
By expanding its healthcare diplomacy, India sets a precedent for collaboration and innovation in global health, bridging gaps and promoting equity on a broader scale.
